Ping Zhong Selected Research

Dopamine D4 Receptors (Dopamine D4 Receptor)

11/2016	The ADHD-linked human dopamine D4 receptor variant D4.7 induces over-suppression of NMDA receptor function in prefrontal cortex.
1/2016	Distinct Physiological Effects of Dopamine D4 Receptors on Prefrontal Cortical Pyramidal Neurons and Fast-Spiking Interneurons.
1/2016	Aberrant regulation of synchronous network activity by the attention-deficit/hyperactivity disorder-associated human dopamine D4 receptor variant D4.7 in the prefrontal cortex.
9/2013	Restoration of glutamatergic transmission by dopamine D4 receptors in stressed animals.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ping Zhong Research Topics

Disease

20	Neoplasms (Cancer) 09/2022 - 11/2011
8	Ischemic Stroke 01/2022 - 01/2017
7	Autistic Disorder (Autism) 08/2022 - 06/2015
6	Hypertension (High Blood Pressure) 01/2022 - 07/2009
6	Stroke (Strokes) 12/2021 - 01/2017
6	Infections 01/2021 - 11/2004
6	Glioma (Gliomas) 09/2017 - 11/2011
5	COVID-19 11/2022 - 01/2020
5	Mental Disorders (Mental Disorder) 01/2020 - 05/2004
5	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 11/2016 - 12/2010
4	Body Weight (Weight, Body) 03/2022 - 01/2017
4	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2016
4	Meningioma (Meningiomas) 01/2019 - 02/2013
4	Glioblastoma (Glioblastoma Multiforme) 11/2018 - 02/2014
4	Disease Progression 10/2017 - 08/2011
4	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 05/2003
4	Schizophrenia (Dementia Praecox) 01/2016 - 01/2006
3	Acoustic Neuroma (Acoustic Neurinoma) 01/2021 - 08/2019
3	Breast Neoplasms (Breast Cancer) 01/2020 - 11/2016
3	Melanoma (Melanoma, Malignant) 10/2017 - 07/2017
2	Pneumonia (Pneumonitis) 11/2022 - 01/2021
2	Weight Loss (Weight Reduction) 03/2022 - 01/2021
2	Neuroinflammatory Diseases 01/2022 - 01/2019
2	Inflammation (Inflammations) 12/2021 - 07/2015
2	Underactive Urinary Bladder 05/2021 - 01/2020
2	Ischemia 02/2021 - 01/2008
2	Dyspnea (Shortness of Breath) 01/2021 - 01/2020
2	Virus Diseases (Viral Diseases) 01/2021 - 12/2014
2	Hypersensitivity (Allergy) 05/2020 - 04/2009
2	Cerebral Infarction 10/2019 - 08/2011
2	Headache (Headaches) 01/2018 - 04/2009
2	Huntington Disease (Huntington's Disease) 05/2012 - 09/2011
2	Nasopharyngeal Carcinoma 12/2004 - 10/2002
2	Heart Failure 02/2003 - 07/2002
1	Hypocalcemia 07/2022
1	Obesity 03/2022
1	Overweight 03/2022
1	Paraplegia (Spastic Paraplegia) 01/2022
1	Autism Spectrum Disorder 01/2022
1	Rupture 01/2022

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2006
11	Pharmaceutical PreparationsIBA 01/2021 - 12/2014
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2014
5	ProdrugsIBA 10/2017 - 11/2016
4	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2019
4	BilirubinIBA 12/2021 - 07/2019
4	Maytansine (Maitansine)IBA 10/2017 - 11/2016
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2016 - 01/2006
4	Dopamine D4 Receptors (Dopamine D4 Receptor)IBA 11/2016 - 09/2013
3	Histones (Histone)IBA 08/2022 - 10/2020
3	ChromatinIBA 08/2022 - 10/2020
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
3	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 01/2008
3	AlbuminsIBA 12/2021 - 01/2020
3	Biological ProductsIBA 01/2021 - 05/2006
3	VaccinesIBA 11/2018 - 12/2014
3	Matrix Metalloproteinases (MMPs)IBA 10/2017 - 01/2017
3	Cholinergic Agents (Cholinergics)IBA 10/2014 - 05/2003
2	Histone DemethylasesIBA 08/2022 - 01/2021
2	CalciumIBA 07/2022 - 10/2019
2	semaglutideIBA 03/2022 - 01/2021
2	Blood Glucose (Blood Sugar)IBA 02/2021 - 01/2021
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 01/2020
2	Alanine Transaminase (SGPT)IBA 01/2021 - 01/2020
2	fibrin fragment D (D-dimer)IBA 01/2021 - 01/2020
2	C-Reactive ProteinIBA 01/2021 - 01/2020
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2020
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 01/2020
2	Peptides (Polypeptides)IBA 01/2021 - 05/2003
2	Oxygen (Dioxygen)IBA 01/2021 - 10/2019
2	Therapeutic UsesIBA 01/2021 - 02/2014
2	LipidsIBA 01/2021 - 01/2021
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2021 - 01/2020
2	Histone MethyltransferasesIBA 10/2020 - 10/2020
2	EnzymesIBA 10/2020 - 07/2014
2	AntigensIBA 11/2018 - 11/2011
2	Kallikreins (Kallikrein)IBA 01/2018 - 01/2017
2	IntegrinsIBA 10/2017 - 01/2017
2	myosin VIIBA 09/2017 - 03/2016
2	MicellesIBA 07/2017 - 08/2013
2	Phencyclidine (Angel Dust)IBA 01/2016 - 01/2006
2	N-Methylaspartate (NMDA)IBA 10/2014 - 06/2008
2	Neutralizing AntibodiesIBA 11/2012 - 01/2005
2	Serotonin (5 Hydroxytryptamine)IBA 06/2008 - 05/2004
2	ChloridesIBA 12/2004 - 10/2002
1	Troponin IIBA 11/2022
1	Capsules (Microcapsules)IBA 09/2022
1	Lysine (L-Lysine)FDA Link 08/2022
1	Parathyroid Hormone (Parathormone)IBA 07/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022
1	Tobacco Smoke Pollution (Passive Smoking)IBA 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022

Therapy/Procedure

18	Therapeutics 03/2022 - 01/2008
6	Radiotherapy 01/2021 - 12/2013
5	Drug Therapy (Chemotherapy) 01/2021 - 06/2016
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 09/2021 - 12/2019
2	Moxibustion 11/2021 - 08/2011
2	Craniotomy 01/2019 - 09/2018
1	Length of Stay 11/2022